Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Wenzler

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Diagnostic Microbiology and Infectious Disease|April 10, 2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacteralesMark Biagi, Michelle Lee, Tiffany Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards InstituteNavaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult SubjectsEric Wenzler, Mark H Gotfried, Jeffrey S Loutit, et al.
Infectious Diseases and Therapy|June 1, 2023
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods ReviewLuke S P Moore, Maria Virginia Villegas, Eric Wenzler, et al.
Drugs in Context|August 5, 2021
Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamideSarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult SubjectsKristen L Bunnell, Manjunath P Pai, Monica Sikka, et al.
Infectious Disease Reports|September 25, 2021
Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> Meningitis and BacteremiaEric Wenzler, Alina Adeel, Tiffany Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2024
Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute2Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Infection and Drug Resistance|January 27, 2021
Therapeutic Options for Metallo-β-Lactamase-Producing EnterobacteralesXing Tan, Hwan Seung Kim, Kimberly Baugh, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United StatesKenneth P Klinker, Levita K Hidayat, Eric Wenzler, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Diagnostic Microbiology and Infectious Disease|April 10, 2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacteralesMark Biagi, Michelle Lee, Tiffany Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards InstituteNavaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult SubjectsEric Wenzler, Mark H Gotfried, Jeffrey S Loutit, et al.
Infectious Diseases and Therapy|June 1, 2023
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods ReviewLuke S P Moore, Maria Virginia Villegas, Eric Wenzler, et al.
Drugs in Context|August 5, 2021
Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamideSarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult SubjectsKristen L Bunnell, Manjunath P Pai, Monica Sikka, et al.
Infectious Disease Reports|September 25, 2021
Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> Meningitis and BacteremiaEric Wenzler, Alina Adeel, Tiffany Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2024
Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute2Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Infection and Drug Resistance|January 27, 2021
Therapeutic Options for Metallo-β-Lactamase-Producing EnterobacteralesXing Tan, Hwan Seung Kim, Kimberly Baugh, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United StatesKenneth P Klinker, Levita K Hidayat, Eric Wenzler, et al.
Pageof 8